(Q52621229)

4 May 2018

title

Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels. (English)

1 reference

4 May 2018

author name string

F Leonhardt

1

1 reference

4 May 2018

K Zirlik

2

1 reference

4 May 2018

M Buchner

3

1 reference

4 May 2018

G Prinz

4

1 reference

4 May 2018

A-K Hechinger

5

1 reference

4 May 2018

U V Gerlach

6

1 reference

4 May 2018

P Fisch

7

1 reference

4 May 2018

A Schmitt-Gräff

8

1 reference

4 May 2018

W Reichardt

9

1 reference

4 May 2018

R Zeiser

10

1 reference

4 May 2018

publication date

17 January 2012

1 reference

4 May 2018

published in

Leukemia

1 reference

4 May 2018

volume

26

1 reference

4 May 2018

issue

7

1 reference

4 May 2018

page(s)

1617-1629

1 reference

4 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2012.10

exact match

0 references

cites work

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

A fundamental role of mAbp1 in neutrophils: impact on beta(2) integrin-mediated phagocytosis and adhesion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

IL-17 contributes to CD4-mediated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Properties of murine (CD8+)CD27- T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

SLP-76 couples Syk to the osteoclast cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Exploiting tolerance processes in transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

T cell signal regulation by the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

Donor APCs are required for maximal GVHD but not for GVL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

Tyrosine phosphorylation and association of Syk with Fc gamma RII in monocytic THP-1 cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

Target antigens determine graft-versus-host disease phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: important roles for soluble factors and tissue microenvironments

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.10

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.10

1 reference

4 May 2018

PubMed ID

22301676

1 reference

4 May 2018